The detailed information for PTAB case with proceeding number IPR2018-00153 filed by Apotex Inc. et al. against Abraxis Biosciences, LLC et al. on Nov 9, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00153
Filing Date
Nov 9, 2017
Petitioner
Apotex Inc. et al.
Respondent
Abraxis Biosciences, LLC et al.
Status
Terminated-Settled
Respondent Application Number
12758413
Respondent Tech Center
1600
Respondent Patent Number
7923536
Institution Decision Date
May 8, 2018
Termination Date
Jul 13, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Decision Document

Jul 13, 2018PAPERBOARD

EX2093 (confidential)

Jun 21, 2018EXHIBITPATENT OWNER

2018-06-21 Joint Request to File Settlement Agreement as Confidential

Jun 21, 2018PAPERPATENT OWNER

Trial Instituted Document

May 8, 2018PAPERBOARD

Errata Sheet IPR2018-00153

Mar 1, 2018PAPERPATENT OWNER

EX2001

Feb 16, 2018EXHIBITPATENT OWNER

EX2003

Feb 16, 2018EXHIBITPATENT OWNER

EX2008

Feb 16, 2018EXHIBITPATENT OWNER

EX2009

Feb 16, 2018EXHIBITPATENT OWNER

EX2014

Feb 16, 2018EXHIBITPATENT OWNER

EX2017

Feb 16, 2018EXHIBITPATENT OWNER

EX2018

Feb 16, 2018EXHIBITPATENT OWNER

EX2028

Feb 16, 2018EXHIBITPATENT OWNER

EX2030

Feb 16, 2018EXHIBITPATENT OWNER

2018-02-16 Patent Owner Preliminary Response IPR2018-00153

Feb 16, 2018PAPERPATENT OWNER

EX2002

Feb 16, 2018EXHIBITPATENT OWNER

EX2004

Feb 16, 2018EXHIBITPATENT OWNER

EX2005

Feb 16, 2018EXHIBITPATENT OWNER

EX2006

Feb 16, 2018EXHIBITPATENT OWNER

EX2007

Feb 16, 2018EXHIBITPATENT OWNER

EX2010

Feb 16, 2018EXHIBITPATENT OWNER

EX2011

Feb 16, 2018EXHIBITPATENT OWNER

EX2012

Feb 16, 2018EXHIBITPATENT OWNER

EX2013

Feb 16, 2018EXHIBITPATENT OWNER

EX2015

Feb 16, 2018EXHIBITPATENT OWNER

EX2016

Feb 16, 2018EXHIBITPATENT OWNER

EX2019

Feb 16, 2018EXHIBITPATENT OWNER

EX2020

Feb 16, 2018EXHIBITPATENT OWNER

EX2029

Feb 16, 2018EXHIBITPATENT OWNER

EX2031

Feb 16, 2018EXHIBITPATENT OWNER

EX2033

Feb 16, 2018EXHIBITPATENT OWNER

EX2035

Feb 16, 2018EXHIBITPATENT OWNER

EX2039

Feb 16, 2018EXHIBITPATENT OWNER

EX2040

Feb 16, 2018EXHIBITPATENT OWNER

EX2041

Feb 16, 2018EXHIBITPATENT OWNER

EX2042

Feb 16, 2018EXHIBITPATENT OWNER

EX2043

Feb 16, 2018EXHIBITPATENT OWNER

EX2044

Feb 16, 2018EXHIBITPATENT OWNER

EX2045

Feb 16, 2018EXHIBITPATENT OWNER

EX2032

Feb 16, 2018EXHIBITPATENT OWNER

EX2034

Feb 16, 2018EXHIBITPATENT OWNER

EX2036

Feb 16, 2018EXHIBITPATENT OWNER

EX2038

Feb 16, 2018EXHIBITPATENT OWNER

EX2055

Feb 16, 2018EXHIBITPATENT OWNER

EX2058

Feb 16, 2018EXHIBITPATENT OWNER

EX2066

Feb 16, 2018EXHIBITPATENT OWNER

EX2068

Feb 16, 2018EXHIBITPATENT OWNER

EX2069

Feb 16, 2018EXHIBITPATENT OWNER

EX2079

Feb 16, 2018EXHIBITPATENT OWNER

EX2050

Feb 16, 2018EXHIBITPATENT OWNER

EX2052

Feb 16, 2018EXHIBITPATENT OWNER

EX2053

Feb 16, 2018EXHIBITPATENT OWNER

EX2054

Feb 16, 2018EXHIBITPATENT OWNER

EX2057

Feb 16, 2018EXHIBITPATENT OWNER

EX2059

Feb 16, 2018EXHIBITPATENT OWNER

EX2060

Feb 16, 2018EXHIBITPATENT OWNER

EX2061

Feb 16, 2018EXHIBITPATENT OWNER

EX2067

Feb 16, 2018EXHIBITPATENT OWNER

EX2070

Feb 16, 2018EXHIBITPATENT OWNER

EX2071

Feb 16, 2018EXHIBITPATENT OWNER

EX2072

Feb 16, 2018EXHIBITPATENT OWNER

EX2073

Feb 16, 2018EXHIBITPATENT OWNER

EX2074

Feb 16, 2018EXHIBITPATENT OWNER

EX2075

Feb 16, 2018EXHIBITPATENT OWNER

EX2076

Feb 16, 2018EXHIBITPATENT OWNER

EX2077

Feb 16, 2018EXHIBITPATENT OWNER

EX2078

Feb 16, 2018EXHIBITPATENT OWNER

EX2080

Feb 16, 2018EXHIBITPATENT OWNER

EX2082

Feb 16, 2018EXHIBITPATENT OWNER

EX2083

Feb 16, 2018EXHIBITPATENT OWNER

EX2084

Feb 16, 2018EXHIBITPATENT OWNER

EX2086

Feb 16, 2018EXHIBITPATENT OWNER

EX2087

Feb 16, 2018EXHIBITPATENT OWNER

EX2088

Feb 16, 2018EXHIBITPATENT OWNER

EX2089

Feb 16, 2018EXHIBITPATENT OWNER

EX2081

Feb 16, 2018EXHIBITPATENT OWNER

EX2085

Feb 16, 2018EXHIBITPATENT OWNER

EX2091

Feb 16, 2018EXHIBITPATENT OWNER

EX2090

Feb 16, 2018EXHIBITPATENT OWNER

EX2092

Feb 16, 2018EXHIBITPATENT OWNER

Reply To Patent Owners Opposition To Petitioners Motion For Joinder

Jan 10, 2018PAPERPETITIONER

Ex. 1029 Panacea Biotech Annual Report 2016-2017

Jan 10, 2018EXHIBITPETITIONER

Petitioners Updated Exhibit List

Jan 10, 2018PAPERPETITIONER

Ex. 1027 E-mail chain between Petitioners and Patent Owners Counsel re additional discovery

Jan 10, 2018EXHIBITPETITIONER

Ex. 1028 Panacea US Certificate of Dissolution

Jan 10, 2018EXHIBITPETITIONER

Patent Owner's Opposition to Joinder IPR2018-00153

Dec 11, 2017PAPERPATENT OWNER

Mandatory Notice IPR2018-00153

Nov 30, 2017PAPERPATENT OWNER

Notice of Accord Filing Date

Nov 16, 2017PAPERBOARD

Petitioners' Power Of Attorney

Nov 9, 2017PAPERPETITIONER

U.S. Patent No. 7,923,536

Nov 9, 2017EXHIBITPETITIONER

Declaration of Cory J. Berkland, Ph.D.

Nov 9, 2017EXHIBITPETITIONER

WO 2000/006152

Nov 9, 2017EXHIBITPETITIONER

FDA Guideline on Sterile Drug Products Produced by Aseptic Processing

Nov 9, 2017EXHIBITPETITIONER

Elan Pharma Intl Ltd. v. Abraxis BioScience, Inc., Sixth Day of Trial

Nov 9, 2017EXHIBITPETITIONER

Elan Pharma Intl Ltd. v. Abraxis BioScience, Inc., Seventh Day of Trial

Nov 9, 2017EXHIBITPETITIONER

U.S. Patent No. 5,498,421

Nov 9, 2017EXHIBITPETITIONER

Patient Information Leaflet, ABRAXANE for Injectable Suspension

Nov 9, 2017EXHIBITPETITIONER

Damascelli, B et al. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles

Nov 9, 2017EXHIBITPETITIONER

U.S. Patent No. 5,439,686

Nov 9, 2017EXHIBITPETITIONER

U.S. Patent No. 5,399,363

Nov 9, 2017EXHIBITPETITIONER

WO 1999/000113

Nov 9, 2017EXHIBITPETITIONER

Li et al., Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis.

Nov 9, 2017EXHIBITPETITIONER

Taxol Label

Nov 9, 2017EXHIBITPETITIONER

EMEA Guidance on Manufacture of the Finished Dosage Form

Nov 9, 2017EXHIBITPETITIONER

Elan Pharma Int Ltd. v. Abraxis BioScience, Inc., Judgment and Verdict Form

Nov 9, 2017EXHIBITPETITIONER

Administrative Documents, New Drug Application No. 21-660

Nov 9, 2017EXHIBITPETITIONER

Ibrahim et al., Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Non-Final Office Action (mailed Apr. 28, 2009)

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Amendment in Response to Non-Final Office Action (dated Oct. 27, 2009)

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Final Office Action (mailed Dec. 31, 2009)

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Amendment After Final Action Under 37 C.F.R. 1.116 (dated Apr. 14, 2010)

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Declaration of Neil P. Desai Pursuant to 37 C.F.R. 1.132 (dated Apr. 14, 2010)

Nov 9, 2017EXHIBITPETITIONER

U.S. Application No. 11/553,339, Notice of Allowance and Fee(s) Due (mailed June 1, 2010)

Nov 9, 2017EXHIBITPETITIONER

FDA, Approved Drug Products with Therapeutic Equivalence Evaluations

Nov 9, 2017EXHIBITPETITIONER

U.S. Patent No. 5,916,596

Nov 9, 2017EXHIBITPETITIONER

Petition for Inter Partes Review

Nov 9, 2017PAPERPETITIONER

Petitioners' Motion for Joinder Pursuant to 35 U.S.C. ¿¿ 315(c) AND 37 C.F.R. ¿¿¿¿ 42.22 & 42.122(b)

Nov 9, 2017PAPERPETITIONER